Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Annals of Surgical Oncology
Published in: Annals of Surgical Oncology 3/2017

01-12-2017 | Endocrine Tumors

Comment on: Eucalcemic Parathyroid Hormone Elevation After Parathyroidectomy for Primary Sporadic Hyperparathyroidism: Risk Factors, Trend, and Outcome

Authors: P. V. Pradeep, MS, DNB, MRCS, FRCS, MCh, B. R. Srikanth, MD

Published in: Annals of Surgical Oncology | Special Issue 3/2017

Login to get access

Excerpt

We read the article “Eucalcemic parathyroid hormone elevation after parathyroidectomy for primary sporadic hyperparathyroidism: risk factors, trend, and outcome” by Lang et al.1 with interest. The authors have addressed a very valid and important scenario after parathyroidectomy. We made similar observations earlier in our patients. We also found that parathyroid hormone (PTH) levels and recovery of bones after surgery were influenced by vitamin D (Vit D) deficiency.2 We have certain comments and queries regarding this study. …
Literature
1.
2.
Pradeep PV, Mishra A, Agarwal G, Agarwal A, Verma AK, Mishra SK. Long-term outcome after parathyroidectomy in patients with advanced primary hyperparathyroidism and associated vitamin D deficiency. World J Surg. 2008;32(5):829–35CrossRefPubMed
Metadata
Title
Comment on: Eucalcemic Parathyroid Hormone Elevation After Parathyroidectomy for Primary Sporadic Hyperparathyroidism: Risk Factors, Trend, and Outcome
Authors
P. V. Pradeep, MS, DNB, MRCS, FRCS, MCh
B. R. Srikanth, MD
Publication date
01-12-2017
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue Special Issue 3/2017
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-017-6202-y

Other articles of this Special Issue 3/2017

Annals of Surgical Oncology 3/2017 Go to the issue

Erratum

Erratum to: Axillary Micrometastases and Isolated Tumor Cells Are Not an Indication for Post-mastectomy Radiotherapy in Stage 1 and 2 Breast Cancer

Colorectal Cancer

Comment on: Risk Factors for Survival After Lung Metastasectomy for Colorectal Cancer Patients

Colorectal Cancer

Reply: “Adjuvant” Hyperthermic Intraperitoneal Chemotherapy: A Call to Action

Gastrointestinal Oncology

Open Versus Minimally Invasive Resection of Gastric GIST: A Multi-Institutional Analysis of Short- and Long-Term Outcomes: A Reply

Breast Oncology

Comment on: Sentinel Node Biopsy Using Magnetic Tracer Versus Standard Technique: The SentiMAG Multicentre Trial

Head and Neck Oncology

Factors Influencing the Decision on Surgery or Observation for Patients with Bethesda Category 3 (AUS/FLUS)